This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The i-GelTM. A Randomized, Crossover Study With the Laryngeal Mask Airway ProSealTM in Anesthetized Pediatric Patients

This study has been completed.
Information provided by (Responsible Party):
ChristianKeller, Schulthess Klinik Identifier:
First received: August 26, 2011
Last updated: September 20, 2011
Last verified: September 2011
In the following randomized, crossover study, the investigators test the hypothesis that ease of insertion and oropharyngeal leak pressure differ between the LMA ProSealTM and the i-GelTM in anesthetized pediatric patients.

Condition Intervention
Device Success Rate Device Performance Device: i-Gel Device: ProSeal

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science

Further study details as provided by ChristianKeller, Schulthess Klinik:

Primary Outcome Measures:
  • Oropharyngeal leak pressure [ Time Frame: 10 Minutes ]

Secondary Outcome Measures:
  • Insertion success rate [ Time Frame: 1 Minute ]

Estimated Enrollment: 60
Study Start Date: January 2010
Study Completion Date: September 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: i-Gel Device: i-Gel
Oropharyngeal leak pressure Insertion success
Experimental: ProSeal Device: ProSeal
Oropharyngeal leak pressure Insertion success


Ages Eligible for Study:   18 Months to 6 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • ASA I and II
  • Age 1.5-6 years

Exclusion Criteria:

  • known or predicted difficult airway
  • body mass index > 35 kg m-2
  • risk of aspiration
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01425151

Klinik für Anästhesie und Allgemeine Intensivmedizin
Innsbruck, Austria, 6020
Christian Keller
Zürich, Switzerland, 8008
Sponsors and Collaborators
Schulthess Klinik
Principal Investigator: Christian Keller, MD, M.Sc. Schulthess Klinik
  More Information

Responsible Party: ChristianKeller, MD, M.Sc., Schulthess Klinik Identifier: NCT01425151     History of Changes
Other Study ID Numbers: Schulthess_Anä_2
Study First Received: August 26, 2011
Last Updated: September 20, 2011 processed this record on June 23, 2017